after-pains after normal delivery. Encounter for routine postpartum follow-up
Conditions
Interventions
Intervention 1: Intervention group: Elaeagnus angustifolia will be purchased from centers approved by the Faculty of Iranian and Complementary Medicine, and after grinding, it will be soaked in 70% hy
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: have the desire to enter the study. age between 18 to 35 years old. At least be literate in reading and writing. The current birth be the second to fourth birth. Normal delivery, singleton and full term. (Based on the ultrasound of the first trimester or last menstrual valid period) The baby be alive and healthy. If there are pains with a score of 4 to 10 based on the pain ruler. Cephalic presentation. The baby's weight should be 2500-4000 grams. (weighing recorded in the baby's file) Not to have any past medical and mental history. (heart disease, chronic Hypertension, and pre-eclampsia, diabetes, kidney and lung disease, autoimmune diseases and all types of neurological and mental diseases) Not to be allergic to Elaeagnus angustifolia. (Symptoms of allergy include: rhinitis, rhinoconjunctivitis, dermatitis) Not to be addicted to drugs, psychotropic substances, alcohol or tobacco. Not to have severe post partum bleeding after delivery.(Bleeding that requires medical measures (other than receiving centocinone) or requiring blood transfer and moving to operating room.) Not having any history of uterine surgery or caesarean section Drug analgesia has not been used to reduce labor pain.(Spinal, Epidural, Entonox gas) Not to have 3 and 4 perineum tears. The first, second, and third stages of labor should be normal.(First stage: no fast or slow progressing labor, no prolonged rupture of membranes (more than 12 hours), second stage: no instrumental labor, no third and fourth degree rupture, third stage: spontaneous exit of the placenta and membranes)
Exclusion criteria
Exclusion criteria: Not intend to continue the research Mother's refusal to take more than one capsule of Elaeagnus angustifolia or placebo The impossibility of continuing to breastfeed the baby (Due to the death of the baby, hospitalization in NICU) Any problem that disturbs the routine care of the mother.(Transferring the mother to the operating room-early discharge before 24 hours-hemorrhage or any obstetric problems of the mother that require treatment.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of after pain. Timepoint: After 2 hours after delivery, Elaeagnus angustifolia fruit extract capsule or placebo is given to the mother every 6 hours to 24 hours, and the intensity of after pain is measured one hour after each drug dose. Method of measurement: Painometer-visual analogue scale, which is one of the parts of the painometer tool, will be used to measure pain intensity.;Quality of after pain. Timepoint: After 2 hours after delivery, Elaeagnus angustifolia fruit extract capsule or placebo are given to the mother every 6 hours, and the quality of after pain is measured one hour after receiving each drug dose. Method of measurement: To evaluate the quality of pain, the word description scale index, which is one of the parts of the painometer tool, will be used. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Parvin Zabeti Asnad Astaneh
Mashhad University of Medical Sciences
Outcome results
None listed